| scholarly article | Q13442814 |
| P356 | DOI | 10.1124/PR.117.014050 |
| P8608 | Fatcat ID | release_asljy32kfbdxdoimqezolf2mle |
| P932 | PMC publication ID | 5629631 |
| P698 | PubMed publication ID | 28978633 |
| P2093 | author name string | Andreas Papapetropoulos | |
| Csaba Szabo | |||
| P2860 | cites work | Kinetics and inhibition of recombinant human cystathionine gamma-lyase. Toward the rational control of transsulfuration | Q22009446 |
| Structure of human cystathionine beta-synthase: a unique pyridoxal 5'-phosphate-dependent heme protein | Q24291509 | ||
| Production of the neuromodulator H2S by cystathionine beta-synthase via the condensation of cysteine and homocysteine | Q24310423 | ||
| Human cystathionine beta-synthase is a target for sumoylation | Q24312724 | ||
| Structural basis for the inhibition mechanism of human cystathionine gamma-lyase, an enzyme responsible for the production of H(2)S | Q24316078 | ||
| Crystal structure of Escherichia coli cystathionine gamma-synthase at 1.5 A resolution | Q24533426 | ||
| Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation | Q24597604 | ||
| Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxation | Q24656291 | ||
| Hydrogen sulfide mediates the vasoactivity of garlic | Q24673752 | ||
| Hydrogen Sulfide and Cellular Redox Homeostasis | Q26765798 | ||
| Nitric oxide: physiology, pathophysiology, and pharmacology | Q26778243 | ||
| Cysteine and hydrogen sulphide in the regulation of metabolism: insights from genetics and pharmacology | Q26782965 | ||
| Homocysteine-Induced Endothelial Dysfunction | Q26800839 | ||
| Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease | Q26823796 | ||
| A critical review of pharmacological significance of Hydrogen Sulfide in hypertension | Q26824749 | ||
| The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning | Q26825733 | ||
| The role of H2S bioavailability in endothelial dysfunction | Q26851344 | ||
| A tale of two gases: NO and H2S, foes or friends for life? | Q27002433 | ||
| Role of homocysteine in the development of cardiovascular disease | Q27004318 | ||
| H2S during circulatory shock: some unresolved questions | Q27006240 | ||
| Signaling molecules: hydrogen sulfide and polysulfide | Q27024480 | ||
| Expression of mutant human cystathionine beta-synthase rescues neonatal lethality but not homocystinuria in a mouse model | Q34131334 | ||
| Effect of S-adenosyl-L-methionine (SAM), an allosteric activator of cystathionine-β-synthase (CBS) on colorectal cancer cell proliferation and bioenergetics in vitro | Q34145385 | ||
| Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? | Q34157091 | ||
| The resurgence of covalent drugs | Q34174891 | ||
| Acquired sulfhemoglobinemia. An underreported diagnosis? | Q34189973 | ||
| Structural insight into the molecular mechanism of allosteric activation of human cystathionine β-synthase by S-adenosylmethionine | Q34218322 | ||
| Solubility and permeation of hydrogen sulfide in lipid membranes. | Q34235296 | ||
| Studies on the GABA pathway. I. The inhibition of gamma-aminobutyric acid-alpha-ketoglutaric acid transaminase in vitro and in vivo by U-7524 (amino-oxyacetic acid). | Q34249568 | ||
| NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model | Q34256975 | ||
| Failure of aminooxyacetic acid therapy in Huntington disease | Q34260726 | ||
| Reactivity of the phosphopyridoxal groups of cystathionase | Q34362228 | ||
| Sulfide inhibition of and metabolism by cytochrome c oxidase. | Q34372858 | ||
| A novel controllable hydrogen sulfide-releasing molecule protects human skin keratinocytes against methylglyoxal-induced injury and dysfunction | Q34381184 | ||
| Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition. | Q34402692 | ||
| Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent | Q34403540 | ||
| Release of GLP-1 and PYY in response to the activation of G protein-coupled bile acid receptor TGR5 is mediated by Epac/PLC-ε pathway and modulated by endogenous H2S. | Q34441486 | ||
| H2S-releasing drugs: anti-inflammatory, cytoprotective and chemopreventative potential | Q34451352 | ||
| Correction of disease-causing CBS mutations in yeast | Q34468374 | ||
| Down-regulation of hydrogen sulfide biosynthesis accompanies murine interstitial cells of Cajal dysfunction in partial ileal obstruction | Q34469660 | ||
| AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro | Q34477537 | ||
| Gaseous mediators in resolution of inflammation | Q34481627 | ||
| MPST but not CSE is the primary regulator of hydrogen sulfide production and function in the coronary artery. | Q34500007 | ||
| Cystathionine β-synthase and cystathionine γ-lyase double gene transfer ameliorate homocysteine-mediated mesangial inflammation through hydrogen sulfide generation | Q34501679 | ||
| Expression profile of hydrogen sulfide and its synthases correlates with tumor stage and grade in urothelial cell carcinoma of bladder | Q34512480 | ||
| Upregulation of cystathionine β-synthetase expression contributes to visceral hyperalgesia induced by heterotypic intermittent stress in rats | Q34535038 | ||
| cGMP-dependent protein kinase contributes to hydrogen sulfide-stimulated vasorelaxation. | Q34535138 | ||
| Sodium thiosulfate attenuates acute lung injury in mice | Q34543931 | ||
| Evaluation of Amino-Oxyacetic Acid as a Palliative in Tinnitus | Q34553596 | ||
| Utilizing hydrogen sulfide as a novel anti-cancer agent by targeting cancer glycolysis and pH imbalance | Q34559610 | ||
| Cytoprotective effects of hydrogen sulfide-releasing N-methyl-D-aspartate receptor antagonists are mediated by intracellular sulfane sulfur | Q34565353 | ||
| H2S induced hypometabolism in mice is missing in sedated sheep | Q34709014 | ||
| Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms. | Q34751757 | ||
| Effect of inhaled hydrogen sulfide on metabolic responses in anesthetized, paralyzed, and mechanically ventilated piglets | Q34778474 | ||
| H2S relaxes isolated human airway smooth muscle cells via the sarcolemmal K(ATP) channel | Q37730872 | ||
| S-propargyl-cysteine, a novel water-soluble modulator of endogenous hydrogen sulfide, promotes angiogenesis through activation of signal transducer and activator of transcription 3. | Q37734005 | ||
| Synthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals | Q37749789 | ||
| Protein modifications involved in neurotransmitter and gasotransmitter signaling | Q37789075 | ||
| Mitochondria and Sulfide: A Very Old Story of Poisoning, Feeding, and Signaling? | Q37804386 | ||
| Hydrogen sulfide and cell signaling. | Q37826422 | ||
| Hydrogen sulfide-mediated myocardial pre- and post-conditioning | Q37849578 | ||
| The therapeutic potential of hydrogen sulfide: separating hype from hope | Q37872122 | ||
| Emerging role of hydrogen sulfide in health and disease: critical appraisal of biomarkers and pharmacological tools | Q37917815 | ||
| The CBS domain: a protein module with an emerging prominent role in regulation | Q37940566 | ||
| Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising | Q37960610 | ||
| Hydrogen sulfide and the metabolic syndrome | Q37960613 | ||
| Roles of hydrogen sulfide in the pathogenesis of diabetes mellitus and its complications | Q37965571 | ||
| Physiological implications of hydrogen sulfide: a whiff exploration that blossomed | Q38005671 | ||
| Evolutionary and comparative aspects of nitric oxide, carbon monoxide and hydrogen sulfide | Q38006568 | ||
| Ventilatory and metabolic effects of exogenous hydrogen sulfide | Q38009551 | ||
| Hydrogen sulphide: biopharmacological roles in the cardiovascular system and pharmaceutical perspectives | Q38017235 | ||
| Regulation of mercaptopyruvate sulfurtransferase activity via intrasubunit and intersubunit redox-sensing switches | Q38059256 | ||
| Prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs), more than meets the eye: a critical review | Q38068081 | ||
| Hydrogen sulfide signaling in the gastrointestinal tract | Q38098623 | ||
| Molecular mechanisms for the anti-cancer effects of diallyl disulfide | Q38098781 | ||
| Redox Biology of Hydrogen Sulfide: Implications for Physiology, Pathophysiology, and Pharmacology | Q38116513 | ||
| Physiological role of hydrogen sulfide and polysulfide in the central nervous system. | Q38137646 | ||
| Role of hydrogen sulfide in secondary neuronal injury | Q38163273 | ||
| Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis | Q38184753 | ||
| Pharmacological tools for hydrogen sulphide research: a brief, introductory guide for beginners | Q38218546 | ||
| Controversies and conundrums in hydrogen sulfide biology | Q38220160 | ||
| Hydrogen sulfide: a neuromodulator and neuroprotectant in the central nervous system | Q38250429 | ||
| Hydrogen sulfide in signaling pathways | Q38274738 | ||
| Protective effect of hydrogen sulfide on pancreatic beta-cells | Q38280662 | ||
| Calorie restriction and methionine restriction in control of endogenous hydrogen sulfide production by the transsulfuration pathway. | Q38293712 | ||
| Role of cGMP in hydrogen sulfide signaling | Q38305532 | ||
| Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases | Q38306132 | ||
| Mechanistic chemical perspective of hydrogen sulfide signaling. | Q38366069 | ||
| GYY4137, a novel water-soluble, H2S-releasing molecule. | Q38366070 | ||
| Hydrogen sulfide signaling: interactions with nitric oxide and reactive oxygen species | Q38381741 | ||
| Safety, tolerability and pharmacokinetics of trimebutine 3-thiocarbamoylbenzenesulfonate (GIC-1001) in a randomized phase I integrated design study: single and multiple ascending doses and effect of food in healthy volunteers | Q38423641 | ||
| Hydrogen sulfide increases thermotolerance and lifespan in Caenorhabditis elegans. | Q36300148 | ||
| Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention? | Q36305199 | ||
| Vasorelaxant Effect of a New Hydrogen Sulfide-Nitric Oxide Conjugated Donor in Isolated Rat Aortic Rings through cGMP Pathway | Q36305319 | ||
| Impaired Hydrogen Sulfide-Mediated Vasodilation Contributes to Microvascular Endothelial Dysfunction in Hypertensive Adults | Q36324582 | ||
| Hydrogen sulfide and PKG in ischemia-reperfusion injury: sources, signaling, accelerators and brakes | Q36341617 | ||
| Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases | Q36342111 | ||
| Sensory and cognitive effects of acute exposure to hydrogen sulfide | Q36381300 | ||
| The hydrogen sulphide-releasing derivative of diclofenac protects against ischaemia-reperfusion injury in the isolated rabbit heart. | Q36381503 | ||
| AP39, A Mitochondrially Targeted Hydrogen Sulfide Donor, Exerts Protective Effects in Renal Epithelial Cells Subjected to Oxidative Stress in Vitro and in Acute Renal Injury in Vivo | Q36385235 | ||
| Garlic-Derived Organic Polysulfides and Myocardial Protection | Q36498005 | ||
| The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver | Q36532353 | ||
| Hydrogen sulfide: both feet on the gas and none on the brake? | Q36561890 | ||
| Upregulation and mitochondrial sequestration of hemoglobins occurs in circulating leukocytes during critical illness, conferring a cytoprotective phenotype | Q36568285 | ||
| SIRT3 Mediates the Antioxidant Effect of Hydrogen Sulfide in Endothelial Cells. | Q36601974 | ||
| Design, Synthesis, and Cardioprotective Effects of N-Mercapto-Based Hydrogen Sulfide Donors. | Q36617377 | ||
| Hydrogen sulfide inhibits proliferation and release of IL-8 from human airway smooth muscle cells | Q36623483 | ||
| Betaine supplementation is less effective than methionine restriction in correcting phenotypes of CBS deficient mice | Q36668621 | ||
| Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats. | Q36682260 | ||
| The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury | Q36713900 | ||
| Hydrogen sulfide modulates chromatin remodeling and inflammatory mediator production in response to endotoxin, but does not play a role in the development of endotoxin tolerance. | Q36758450 | ||
| Hydrogen sulfide (H2S) - the third gas of interest for pharmacologists. | Q36766304 | ||
| D-Penicillamine modulates hydrogen sulfide (H2S) pathway through selective inhibition of cystathionine-γ-lyase | Q36797373 | ||
| Pyridoxal 5'-phosphate enzymes as targets for therapeutic agents | Q36822863 | ||
| Thiosulfate Mediates Cytoprotective Effects of Hydrogen Sulfide Against Neuronal Ischemia | Q36836222 | ||
| Improved tag-switch method reveals that thioredoxin acts as depersulfidase and controls the intracellular levels of protein persulfidation. | Q36837643 | ||
| Hydrogen sulfide preconditions the db/db diabetic mouse heart against ischemia-reperfusion injury by activating Nrf2 signaling in an Erk-dependent manner | Q36838022 | ||
| Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling | Q36844600 | ||
| Polysulfides as biologically active ingredients of garlic | Q36850180 | ||
| Hydrogen Sulfide Is a Novel Regulator of Bone Formation Implicated in the Bone Loss Induced by Estrogen Deficiency | Q36889262 | ||
| H₂S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase | Q36895184 | ||
| A case of mistaken identity: are reactive oxygen species actually reactive sulfide species? | Q36902539 | ||
| Molecular targets of cancer chemoprevention by garlic-derived organosulfides | Q36920765 | ||
| Selectivity of commonly used pharmacological inhibitors for cystathionine β synthase (CBS) and cystathionine γ lyase (CSE). | Q36943270 | ||
| Carbon monoxide, hydrogen sulfide, and nitric oxide as signaling molecules in the gastrointestinal tract | Q27026586 | ||
| Sodium thiosulfate ameliorates oxidative stress and preserves renal function in hyperoxaluric rats | Q27308885 | ||
| Crystal structures of 1-aminocyclopropane-1-carboxylate (ACC) synthase in complex with aminoethoxyvinylglycine and pyridoxal-5'-phosphate provide new insight into catalytic mechanisms | Q27632861 | ||
| Slow-binding inhibition of Escherichia coli cystathionine beta-lyase by L-aminoethoxyvinylglycine: a kinetic and X-ray study | Q27747982 | ||
| Relative contributions of cystathionine beta-synthase and gamma-cystathionase to H2S biogenesis via alternative trans-sulfuration reactions | Q27929768 | ||
| The Role of Hydrogen Sulfide in Renal System | Q28066719 | ||
| Persulfides: current knowledge and challenges in chemistry and chemical biology | Q28083376 | ||
| The Cardioprotective Effects of Hydrogen Sulfide in Heart Diseases: From Molecular Mechanisms to Therapeutic Potential | Q28083965 | ||
| Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs | Q28192729 | ||
| Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation | Q28200154 | ||
| H2S induces a suspended animation-like state in mice | Q28246406 | ||
| Phenazopyridine-induced sulfhemoglobinemia | Q28249837 | ||
| The role of cystathionine beta-synthase in homocysteine metabolism | Q28250320 | ||
| Reproducibility and sensitivity of oral malodor measurements with a portable sulphide monitor | Q28251997 | ||
| Garlic organosulfur compounds upregulate the expression of the pi class of glutathione S-transferase in rat primary hepatocytes | Q28279160 | ||
| Redox regulation and reaction mechanism of human cystathionine-beta-synthase: a PLP-dependent hemesensor protein | Q28296829 | ||
| H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase | Q28298435 | ||
| The antidotal action of sodium nitrite and sodium thiosulfate against cyanide poisoning | Q28305855 | ||
| Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy | Q28306500 | ||
| The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener | Q28363080 | ||
| Selective inhibition of alanine aminotransferase and aspartate aminotransferase in rat hepatocytes | Q28366724 | ||
| Mitochondria as a target in treatment | Q28382780 | ||
| Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling | Q28387183 | ||
| Effects of S-propargyl-cysteine (SPRC) in caerulein-induced acute pancreatitis in mice | Q28481347 | ||
| Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence | Q28482202 | ||
| Therapeutic effect of hydrogen sulfide-releasing L-Dopa derivative ACS84 on 6-OHDA-induced Parkinson's disease rat model | Q28485947 | ||
| 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain | Q28513550 | ||
| Cardioprotective effects of a novel hydrogen sulfide agent-controlled release formulation of S-propargyl-cysteine on heart failure rats and molecular mechanisms | Q28534567 | ||
| Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance | Q28535061 | ||
| Hydrogen sulfide releasing aspirin, ACS14, attenuates high glucose-induced increased methylglyoxal and oxidative stress in cultured vascular smooth muscle cells | Q28539333 | ||
| Domain organization, catalysis and regulation of eukaryotic cystathionine beta-synthases | Q28541958 | ||
| Hydrogen sulfide promotes adipogenesis in 3T3L1 cells | Q28545148 | ||
| Profound Chemopreventative Effects of a Hydrogen Sulfide-Releasing NSAID in the APCMin/+ Mouse Model of Intestinal Tumorigenesis | Q28550361 | ||
| The therapeutic potential of poly(ADP-ribose) polymerase inhibitors | Q34838585 | ||
| Enhanced synthesis and diminished degradation of hydrogen sulfide in experimental colitis: a site-specific, pro-resolution mechanism | Q34938166 | ||
| Hydrogen sulfide preconditioning protects rat liver against ischemia/reperfusion injury by activating Akt-GSK-3β signaling and inhibiting mitochondrial permeability transition | Q34994670 | ||
| Physiological and pathophysiological roles of hydrogen sulfide in the gastrointestinal tract | Q35004267 | ||
| The therapeutic potential of cystathionine β-synthetase/hydrogen sulfide inhibition in cancer | Q35016080 | ||
| Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis | Q35048409 | ||
| The quantitative significance of the transsulfuration enzymes for H2S production in murine tissues | Q35056200 | ||
| Structural insights into mutations of cystathionine beta-synthase. | Q35103607 | ||
| Exogenous hydrogen sulfide (H2S) protects alveolar growth in experimental O2-induced neonatal lung injury | Q35113434 | ||
| Cardioprotective effects of hydrogen sulfide | Q35115617 | ||
| Hydrogen sulfide inhalation decreases early blood-brain barrier permeability and brain edema induced by cardiac arrest and resuscitation | Q35143529 | ||
| The H2S-releasing naproxen derivative, ATB-346, inhibits alveolar bone loss and inflammation in rats with ligature-induced periodontitis. | Q35158599 | ||
| Role of hydrogen sulfide in brain synaptic remodeling | Q35166466 | ||
| Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function | Q35170942 | ||
| Hydrogen sulfide attenuates high fat diet-induced cardiac dysfunction via the suppression of endoplasmic reticulum stress. | Q35181153 | ||
| Arylthioamides as H2S Donors: l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo | Q35181925 | ||
| Exogenous administration of thiosulfate, a donor of hydrogen sulfide, attenuates angiotensin II-induced hypertensive heart disease in rats | Q35204841 | ||
| Crucial role of androgen receptor in vascular H2S biosynthesis induced by testosterone | Q35204849 | ||
| Sodium nitroprusside-induced cyanide intoxication and prevention with sodium thiosulfate prophylaxis | Q35224039 | ||
| PLP-dependent H(2)S biogenesis | Q35353935 | ||
| Hydrogen sulphide and angiogenesis: mechanisms and applications. | Q35375963 | ||
| Cystathionine β-synthase inhibition is a potential therapeutic approach to treatment of ischemic injury | Q35418764 | ||
| Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia | Q35545028 | ||
| Marine natural products as inhibitors of cystathionine beta-synthase activity | Q35558545 | ||
| Nitric oxide-releasing flurbiprofen reduces formation of proinflammatory hydrogen sulfide in lipopolysaccharide-treated rat | Q35566559 | ||
| Administration of hydrogen sulfide via extracorporeal membrane lung ventilation in sheep with partial cardiopulmonary bypass perfusion: a proof of concept study on metabolic and vasomotor effects. | Q35566969 | ||
| Estrogen Replacement Therapy in Ovariectomized Nonpregnant Ewes Stimulates Uterine Artery Hydrogen Sulfide Biosynthesis by Selectively Up-Regulating Cystathionine β-Synthase Expression | Q35603320 | ||
| Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels | Q35603720 | ||
| Hydrogen sulfide attenuates cytokine production through the modulation of chromatin remodeling. | Q35609926 | ||
| Effects of hydrogen sulfide synthesis inhibitors on posthypoxic ventilatory behavior in the C57BL/6J mouse | Q35613970 | ||
| Hydrogen Sulfide Donor GYY4137 Protects against Myocardial Fibrosis. | Q35640723 | ||
| Role of hydrogen sulfide in paramyxovirus infections | Q35641468 | ||
| Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway. | Q35661834 | ||
| GYY4137 protects against myocardial ischemia and reperfusion injury by attenuating oxidative stress and apoptosis in rats | Q35666649 | ||
| Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics | Q39252442 | ||
| Differing effects of exogenous and endogenous hydrogen sulphide in carrageenan-induced knee joint synovitis in the rat. | Q39291389 | ||
| H2S dependent and independent anti-inflammatory activity of zofenoprilat in cells of the vascular wall. | Q39369158 | ||
| Enhanced detection of hydrogen sulfide generated in cell culture using an agar trap method | Q39406950 | ||
| Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect | Q39416914 | ||
| H2S releasing aspirin protects amyloid beta induced cell toxicity in BV-2 microglial cells | Q39501848 | ||
| Thioredoxin and dihydrolipoic acid are required for 3-mercaptopyruvate sulfurtransferase to produce hydrogen sulfide | Q39511939 | ||
| Hydrogen sulfide contributes to hypoxic inhibition of airway transepithelial sodium absorption | Q39578261 | ||
| S-Propargyl-cysteine (SPRC) attenuated lipopolysaccharide-induced inflammatory response in H9c2 cells involved in a hydrogen sulfide-dependent mechanism. | Q39595060 | ||
| Quantitative Persulfide Site Identification (qPerS-SID) Reveals Protein Targets of H2S Releasing Donors in Mammalian Cells | Q39605149 | ||
| Pharmacological postconditioning against myocardial infarction with a slow-releasing hydrogen sulfide donor, GYY4137. | Q39631796 | ||
| GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat. | Q39859585 | ||
| Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346). | Q39884340 | ||
| Hydrogen sulfide depletion contributes to microvascular remodeling in obesity | Q39906675 | ||
| Perspective on recent developments on sulfur-containing agents and hydrogen sulfide signaling | Q40035000 | ||
| Surviving blood loss using hydrogen sulfide | Q40077365 | ||
| Preconditioning of H2S inhalation protects against cerebral ischemia/reperfusion injury by induction of HSP70 through PI3K/Akt/Nrf2 pathway | Q40102686 | ||
| Menadione effect on l-cysteine desulfuration in U373 cells. | Q40129178 | ||
| NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid has enhanced chemo-preventive properties compared to aspirin, is gastrointestinal safe with all the classic therapeutic indications | Q40138226 | ||
| Hydrogen Sulfide in Exhaled Gases From Ventilated Septic Neonates and Children: A Preliminary Report | Q40169637 | ||
| S-allyl cysteine alleviates nonsteroidal anti-inflammatory drug-induced gastric mucosal damages by increasing cyclooxygenase-2 inhibition, heme oxygenase-1 induction, and histone deacetylation inhibition | Q40177294 | ||
| Recombinant adeno-associated virus mediated gene transfer in a mouse model for homocystinuria | Q40187095 | ||
| Cytoprotective and antioxidant role of diallyl tetrasulfide on cadmium induced renal injury: an in vivo and in vitro study | Q40204626 | ||
| Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide | Q40266368 | ||
| Hydrogen sulfide protects HT22 neuronal cells from oxidative stress | Q40283312 | ||
| Protective effects of garlic sulfur compounds against DNA damage induced by direct- and indirect-acting genotoxic agents in HepG2 cells | Q40295924 | ||
| Toxicology of thiono-sulfur compounds | Q40331713 | ||
| Anethole dithiolethione: biochemical considerations | Q40369484 | ||
| Hydrogen Sulfide Is an Antiviral and Antiinflammatory Endogenous Gasotransmitter in the Airways. Role in Respiratory Syncytial Virus Infection. | Q40476846 | ||
| Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats | Q40504398 | ||
| Mitochondrially targeted compounds and their impact on cellular bioenergetics | Q40513041 | ||
| The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'? | Q40535164 | ||
| GYY4137 attenuates remodeling, preserves cardiac function and modulates the natriuretic peptide response to ischemia | Q40646334 | ||
| Dapsone intoxication: two case reports | Q40677801 | ||
| The effect of a hydrogen sulfide releasing molecule (Na2S) on the cold storage of livers from cardiac dead donor rats. A study in an ex vivo model. | Q40818312 | ||
| Hydrogen sulfide improves resuscitation via non-hibernatory mechanisms in a porcine shock model | Q40959455 | ||
| Detection of exhaled hydrogen sulphide gas in healthy human volunteers during intravenous administration of sodium sulphide | Q40985662 | ||
| Effect of CCl4 and blocking H2S biosynthesis on oesophageal mucosa rats: model of nonerosive oesophagitis | Q41043660 | ||
| Active cystathionine beta-synthase can be expressed in heme-free systems in the presence of metal-substituted porphyrins or a chemical chaperone | Q41177625 | ||
| Hydrogen sulfide mediates the cardioprotective effects of gene therapy with PKG-Iα. | Q41189484 | ||
| Cystathionine γ-lyase is expressed in human atherosclerotic plaque microvessels and is involved in micro-angiogenesis | Q41344125 | ||
| Fragment-based de novo design of a cystathionine γ-lyase selective inhibitor blocking hydrogen sulfide production | Q41344548 | ||
| NOSH-aspirin (NBS-1120), a dual nitric oxide and hydrogen sulfide-releasing hybrid, reduces inflammatory pain | Q41360072 | ||
| Hydrogen sulfide poisoning: an antidotal role for sodium nitrite? | Q41484614 | ||
| Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid. | Q41556578 | ||
| A distal ligand mutes the interaction of hydrogen sulfide with human neuroglobin | Q41598860 | ||
| A Novel H2S-releasing Amino-Bisphosphonate which combines bone anti-catabolic and anabolic functions. | Q41696640 | ||
| Hydrogen sulfide-releasing cyclooxygenase inhibitor ATB-346 enhances motor function and reduces cortical lesion volume following traumatic brain injury in mice. | Q41729974 | ||
| Hydrogen sulfide decreases adenosine triphosphate levels in aortic rings and leads to vasorelaxation via metabolic inhibition | Q41906351 | ||
| Organelle-Targeted H2S Probes Enable Visualization of the Subcellular Distribution of H2S Donors | Q41980247 | ||
| Detection of exhaled hydrogen sulphide gas in rats exposed to intravenous sodium sulphide | Q41990618 | ||
| Inhaled hydrogen sulfide protects against lipopolysaccharide-induced acute lung injury in mice | Q41994150 | ||
| Cysteine-activated hydrogen sulfide (H2S) donors. | Q42005921 | ||
| Complementary roles of gasotransmitters CO and H2S in sleep apnea | Q42064248 | ||
| Hydrogen sulfide poisoning treated with hyperbaric oxygen | Q42087523 | ||
| Anethole dithiolethione lowers the homocysteine and raises the glutathione levels in solid tissues and plasma of rats: a novel non-vitamin homocysteine-lowering agent. | Q42120299 | ||
| Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat | Q42122753 | ||
| Interdependency of cystathione γ-lyase and cystathione β-synthase in hydrogen sulfide-induced blood pressure regulation in rats | Q35671857 | ||
| Regulation of Vascular Tone, Angiogenesis and Cellular Bioenergetics by the 3-Mercaptopyruvate Sulfurtransferase/H2S Pathway: Functional Impairment by Hyperglycemia and Restoration by DL-α-Lipoic Acid. | Q35707083 | ||
| Cystathionine beta-synthase: structure, function, regulation, and location of homocystinuria-causing mutations | Q35747052 | ||
| Protective effects of hydrogen sulfide inhalation on oxidative stress in rats with cotton smoke inhalation-induced lung injury | Q35803214 | ||
| Effect of the Inhibition of Hydrogen Sulfide Synthesis on Ischemic Injury and Oxidative Stress Biomarkers in a Transient Model of Focal Cerebral Ischemia in Rats. | Q35811498 | ||
| Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide. | Q35850118 | ||
| Folding and activity of mutant cystathionine β-synthase depends on the position and nature of the purification tag: characterization of the R266K CBS mutant | Q35869955 | ||
| Detrimental effects for colonocytes of an increased exposure to luminal hydrogen sulfide: The adaptive response | Q35916188 | ||
| Hydrogen Sulfide--Mechanisms of Toxicity and Development of an Antidote | Q35923856 | ||
| A practical look at the chemistry and biology of hydrogen sulfide | Q35929034 | ||
| Inhaled hydrogen sulfide prevents endotoxin-induced systemic inflammation and improves survival by altering sulfide metabolism in mice. | Q35929055 | ||
| Hydrogen sulfide in biochemistry and medicine | Q35929408 | ||
| Homocystinuria: a study with low-methionine diet in three patients | Q35934134 | ||
| NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties. | Q36017220 | ||
| Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo | Q36025402 | ||
| The polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability | Q36042694 | ||
| Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis | Q36052635 | ||
| Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide? | Q36054349 | ||
| Dietary treatment of homocystinuria | Q36061315 | ||
| Polymorphic Variants of Human Rhodanese Exhibit Differences in Thermal Stability and Sulfur Transfer Kinetics | Q36093046 | ||
| Mechanistic basis of enzyme-targeted drugs | Q36094899 | ||
| Capsaicin-Sensitive Sensory Nerves Mediate the Cellular and Microvascular Effects of H2S via TRPA1 Receptor Activation and Neuropeptide Release. | Q36104085 | ||
| Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors | Q36111918 | ||
| Increased endogenous H2S generation by CBS, CSE, and 3MST gene therapy improves ex vivo renovascular relaxation in hyperhomocysteinemia | Q36114692 | ||
| Synthesis and anti-cancer potential of the positional isomers of NOSH-aspirin (NBS-1120) a dual nitric oxide and hydrogen sulfide releasing hybrid | Q36119481 | ||
| Biological thiols-triggered hydrogen sulfide releasing microfibers for tissue engineering applications. | Q36173769 | ||
| NOSH-Aspirin: A Novel Nitric Oxide-Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals | Q36176425 | ||
| Cardioprotective effects and pharmacokinetic properties of a controlled release formulation of a novel hydrogen sulfide donor in rats with acute myocardial infarction | Q36185207 | ||
| Nitric Oxide and Hydrogen Sulfide Interact When Modulating Gastric Physiological Functions in Rodents. | Q36198431 | ||
| Toxicology of Hydrogen Sulfide | Q36213459 | ||
| Molecular mechanisms underlying histological and biochemical changes induced by nitrate in rat liver and the efficacy of S-Allylcysteine. | Q36222560 | ||
| H2S, a novel gasotransmitter, involves in gastric accommodation | Q36245777 | ||
| Evidence that d-cysteine protects mice from gastric damage via hydrogen sulfide produced by d-amino acid oxidase | Q36264264 | ||
| S-Propargyl-Cysteine, a Novel Hydrogen Sulfide Donor, Inhibits Inflammatory Hepcidin and Relieves Anemia of Inflammation by Inhibiting IL-6/STAT3 Pathway | Q28554256 | ||
| Thioredoxin-dependent enzymatic activation of mercaptopyruvate sulfurtransferase. An intersubunit disulfide bond serves as a redox switch for activation | Q28567305 | ||
| Hydrogen sulfide-mediated stimulation of mitochondrial electron transport involves inhibition of the mitochondrial phosphodiesterase 2A, elevation of cAMP and activation of protein kinase A | Q28574416 | ||
| Hormonal regulation of cystathionine beta-synthase expression in liver | Q28581820 | ||
| Broad-Range Antiviral Activity of Hydrogen Sulfide Against Highly Pathogenic RNA Viruses | Q28582806 | ||
| S-Propargyl-cysteine, a novel hydrogen sulfide-modulated agent, attenuates lipopolysaccharide-induced spatial learning and memory impairment: Involvement of TNF signaling and NF-κB pathway in rats | Q28583198 | ||
| Biogenesis of reactive sulfur species for signaling by hydrogen sulfide oxidation pathways | Q28601441 | ||
| Discovery and Mechanistic Characterization of Selective Inhibitors of H2S-producing Enzyme: 3-Mercaptopyruvate Sulfurtransferase (3MST) Targeting Active-site Cysteine Persulfide | Q28817472 | ||
| Self-Immolative Thiocarbamates Provide Access to Triggered H2S Donors and Analyte Replacement Fluorescent Probes | Q28829960 | ||
| Synthesis of Amino-ADT Provides Access to Hydrolytically Stable Amide-Coupled Hydrogen Sulfide Releasing Drug Targets | Q28831055 | ||
| Pyridoxal phosphate enzymes: mechanistic, structural, and evolutionary considerations | Q29620045 | ||
| Inhibition of hydrogen sulfide biosynthesis sensitizes lung adenocarcinoma to chemotherapeutic drugs by inhibiting mitochondrial DNA repair and suppressing cellular bioenergetics. | Q30355313 | ||
| H2S-releasing nanoemulsions: a new formulation to inhibit tumor cells proliferation and improve tissue repair. | Q30358087 | ||
| Working with "H2S": facts and apparent artifacts. | Q30363652 | ||
| Human polycomb 2 protein is a SUMO E3 ligase and alleviates substrate-induced inhibition of cystathionine beta-synthase sumoylation | Q30440592 | ||
| Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function | Q30480176 | ||
| Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice. | Q30491252 | ||
| Using a functional enzyme model to understand the chemistry behind hydrogen sulfide induced hibernation. | Q30492583 | ||
| Hydrogen sulfide is an endogenous stimulator of angiogenesis. | Q30492603 | ||
| Redox biochemistry of hydrogen sulfide | Q30495475 | ||
| Hydrogen sulfide (H2S) metabolism in mitochondria and its regulatory role in energy production | Q30505673 | ||
| Is hydrogen sulfide-induced suspended animation general anesthesia? | Q30514252 | ||
| Urinary sulfur metabolites associate with a favorable cardiovascular risk profile and survival benefit in renal transplant recipients | Q30578815 | ||
| A Long-Term and Slow-Releasing Hydrogen Sulfide Donor Protects against Myocardial Ischemia/Reperfusion Injury | Q30855744 | ||
| AP39, a Mitochondria-Targeted Hydrogen Sulfide Donor, Supports Cellular Bioenergetics and Protects against Alzheimer's Disease by Preserving Mitochondrial Function in APP/PS1 Mice and Neurons | Q31071777 | ||
| Sustained-Release Delivery System of a Slow Hydrogen Sulfide Donor, GYY 4137, for Potential Application in Glaucoma | Q31155331 | ||
| The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death | Q33298076 | ||
| Gene expression changes following acute hydrogen sulfide (H2S)-induced nasal respiratory epithelial injury | Q33333240 | ||
| New method for quantification of gasotransmitter hydrogen sulfide in biological matrices by LC-MS/MS. | Q33559882 | ||
| Preclinical assessment of the distribution, metabolism, and excretion of S-propargyl-cysteine, a novel H2S donor, in Sprague-Dawley rats | Q33567488 | ||
| Differential mechanisms underlying neuroprotection of hydrogen sulfide donors against oxidative stress | Q33692977 | ||
| Inhaled hydrogen sulfide: a rapidly reversible inhibitor of cardiac and metabolic function in the mouse | Q33726946 | ||
| Is pharmacological, H₂S-induced 'suspended animation' feasible in the ICU? | Q33764969 | ||
| Interactions of the major metabolite of the cancer chemopreventive drug oltipraz with cytochrome c: a novel pathway for cancer chemoprevention | Q33815474 | ||
| Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models. | Q33873758 | ||
| Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling. | Q38839698 | ||
| Hydrogen sulfide inhalation ameliorates allergen induced airway hypereactivity by modulating mast cell activation | Q38846453 | ||
| Hydrogen Sulfide Treatment Mitigates Renal Allograft Ischemia-Reperfusion Injury during Cold Storage and Improves Early Transplant Kidney Function and Survival Following Allogeneic Renal Transplantation | Q38846635 | ||
| L-Cysteine/D,L-homocysteine-regulated ileum motility via system L and B°(,+) transporter: Modification by inhibitors of hydrogen sulfide synthesis and dietary treatments | Q38850455 | ||
| Discovery of New H2S Releasing Phosphordithioates and 2,3-Dihydro-2-phenyl-2-sulfanylenebenzo[d][1,3,2]oxazaphospholes with Improved Antiproliferative Activity. | Q38856414 | ||
| Diallyl trisulfide protects against high glucose-induced cardiac apoptosis by stimulating the production of cystathionine gamma-lyase-derived hydrogen sulfide | Q38865887 | ||
| The protective effects of endogenous hydrogen sulfide modulator, S-propargyl-cysteine, on high glucose-induced apoptosis in cardiomyocytes: A novel mechanism mediated by the activation of Nrf2. | Q38874251 | ||
| Diallyl trisufide protects against oxygen glucose deprivation -induced apoptosis by scavenging free radicals via the PI3K/Akt -mediated Nrf2/HO-1 signaling pathway in B35 neural cells | Q38884095 | ||
| Garlic-derived natural polysulfanes as hydrogen sulfide donors: Friend or foe? | Q38901220 | ||
| Oxidation of H2S in mammalian cells and mitochondria. | Q38905194 | ||
| Use of phosphorodithioate-based compounds as hydrogen sulfide donors | Q38905197 | ||
| Glutathione-garlic sulfur conjugates: slow hydrogen sulfide releasing agents for therapeutic applications. | Q38917841 | ||
| Sirtuin 6 is essential for sodium sulfide-mediated cytoprotective effect in ischemia/reperfusion-stimulated brain endothelial cells | Q38925091 | ||
| Regulation and role of endogenously produced hydrogen sulfide in angiogenesis | Q38939480 | ||
| Evaluating the anti-neuroinflammatory capacity of raw and steamed garlic as well as five organosulfur compounds. | Q38943205 | ||
| Hydrogen sulfide alleviates hypertensive kidney dysfunction through an epigenetic mechanism | Q38954601 | ||
| Role of the cystathionine γ lyase/hydrogen sulfide pathway in human melanoma progression. | Q38957953 | ||
| Biological chemistry of hydrogen sulfide and persulfides. | Q38971040 | ||
| Hydrogen sulfide, an enhancer of vascular nitric oxide signaling: mechanisms and implications | Q38991916 | ||
| Metabolic, Cardiac, and Renal Effects of the Slow Hydrogen Sulfide-Releasing Molecule GYY4137 During Resuscitated Septic Shock in Swine with Pre-Existing Coronary Artery Disease | Q39010015 | ||
| GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway | Q39023096 | ||
| Functional and Molecular Insights of Hydrogen Sulfide Signaling and Protein Sulfhydration | Q39053014 | ||
| Hydrogen Sulfide as a "Double-Faced" Compound: One with Pro- and Antioxidant Effect | Q39068763 | ||
| Boiling enriches the linear polysulfides and the hydrogen sulfide-releasing activity of garlic | Q39097705 | ||
| Vascular biology of hydrogen sulfide | Q39113984 | ||
| NOSH-aspirin (NBS-1120), a novel nitric oxide and hydrogen sulfide releasing hybrid, attenuates neuroinflammation induced by microglial and astrocytic activation: a new candidate for treatment of neurodegenerative disorders | Q39114886 | ||
| Dysregulation of cystathionine γ-lyase (CSE)/hydrogen sulfide pathway contributes to ox-LDL-induced inflammation in macrophage | Q39122959 | ||
| S-Transnitrosation reactions of hydrogen sulfide (H2S/HS-/S2-) with S-nitrosated cysteinyl thiols in phosphate buffer of pH 7.4: Results and review of the literature | Q39129878 | ||
| Oxidative stress suppresses the cellular bioenergetic effect of the 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway | Q39174189 | ||
| The gasotransmitter hydrogen sulfide induces nrf2-target genes by inactivating the keap1 ubiquitin ligase substrate adaptor through formation of a disulfide bond between cys-226 and cys-613. | Q39245992 | ||
| Synthesis and biological activity of NOSH-naproxen (AVT-219) and NOSH-sulindac (AVT-18A) as potent anti-inflammatory agents with chemotherapeutic potential | Q42159113 | ||
| Light-induced hydrogen sulfide release from "caged" gem-dithiols. | Q42160193 | ||
| Hydrogen Sulfide Oxidation by Myoglobin. | Q42212484 | ||
| Esterase-Sensitive Prodrugs with Tunable Release Rates and Direct Generation of Hydrogen Sulfide. | Q42252277 | ||
| Downregulation of cystathionine β-synthase and cystathionine γ-lyase expression stimulates inflammation in kidney ischemia-reperfusion injury | Q42252740 | ||
| Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2 S availability. | Q42268714 | ||
| Hydrogen Sulfide Prevents Formation of Reactive Oxygen Species through PI3K/Akt Signaling and Limits Ventilator-Induced Lung Injury | Q42321800 | ||
| The Effect of Garlic Derivatives (S-Allylmercaptocysteine, Diallyl Disulfide, and S-Allylcysteine) on Gentamicin Induced Ototoxicity: An Experimental Study. | Q42366049 | ||
| Heme-dependent Metabolite Switching Regulates H2S Synthesis in Response to Endoplasmic Reticulum (ER) Stress. | Q42380152 | ||
| Therapeutic Delivery of H2S via COS: Small Molecule and Polymeric Donors with Benign Byproducts. | Q42381107 | ||
| Controlled release hydrogen sulfide delivery system based on mesoporous silica nanoparticles protects graft endothelium from ischemia-reperfusion injury | Q42407985 | ||
| A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood | Q42429578 | ||
| Cytotoxic effects of hydrogen sulfide on pulmonary alveolar macrophages in rats | Q42476413 | ||
| Mechanism of vasorelaxation and role of endogenous hydrogen sulfide production in mouse aorta. | Q42484213 | ||
| S-Sulfhydration of ATP synthase by hydrogen sulfide stimulates mitochondrial bioenergetics | Q42498020 | ||
| Sildenafil effect on the human bladder involves the L-cysteine/hydrogen sulfide pathway: a novel mechanism of action of phosphodiesterase type 5 inhibitors | Q42510309 | ||
| Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects. | Q42513564 | ||
| Protective and Detrimental Effects of Sodium Sulfide and Hydrogen Sulfide in Murine Ventilator-induced Lung Injury | Q42567549 | ||
| Characterization and interaction studies of two isoforms of the dual localized 3-mercaptopyruvate sulfurtransferase TUM1 from humans | Q42580601 | ||
| Gaseotransmitters: New Frontiers for Translational Science | Q42600835 | ||
| In vitro-controlled release delivery system for hydrogen sulfide donor | Q42752973 | ||
| Inhaled Hydrogen Sulfide Prevents Neurodegeneration and Movement Disorder in a Mouse Model of Parkinson's Disease | Q42764683 | ||
| The hypothesis of the main role of H2S in coupled sulphide-nitroso signalling pathway | Q42778920 | ||
| Pharmacological profile of a novel H(2)S-releasing aspirin | Q42804885 | ||
| A comparative study on the anti-inflammatory effects of single oral doses of naproxen and its hydrogen sulfide (H2S)-releasing derivative ATB-346 in rats with carrageenan-induced synovitis. | Q42861082 | ||
| Thiol-activated gem-dithiols: a new class of controllable hydrogen sulfide donors. | Q42865592 | ||
| Activity of a new hydrogen sulfide-releasing aspirin (ACS14) on pathological cardiovascular alterations induced by glutathione depletion in rats. | Q42913506 | ||
| Crosstalk between hydrogen sulfide and nitric oxide in endothelial cells | Q42914546 | ||
| Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity. | Q42969013 | ||
| Systemic peripheral artery relaxation by KCNQ channel openers and hydrogen sulfide | Q43006034 | ||
| Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide | Q43087876 | ||
| Hydrogen sulfide improves neutrophil migration and survival in sepsis via K+ATP channel activation | Q43118261 | ||
| Modulation of thiol homeostasis induced by H2S-releasing aspirin | Q43156037 | ||
| L-cysteine stimulates hydrogen sulfide synthesis in myocardium associated with attenuation of ischemia-reperfusion injury. | Q43172655 | ||
| Cardiac and metabolic effects of hypothermia and inhaled hydrogen sulfide in anesthetized and ventilated mice | Q43186198 | ||
| Effect of hydrogen sulfide on myocardial protection in the setting of cardioplegia and cardiopulmonary bypass | Q43201845 | ||
| Protective effects of cysteine analogues on acute myocardial ischemia: novel modulators of endogenous H(2)S production. | Q43258277 | ||
| ACS67, a hydrogen sulfide-releasing derivative of latanoprost acid, attenuates retinal ischemia and oxidative stress to RGC-5 cells in culture | Q43285272 | ||
| Biochemical and cytologic alterations in the respiratory tract of rats exposed for 4 hours to hydrogen sulfide | Q43567625 | ||
| Effects of organosulfur compounds from garlic oil on the antioxidation system in rat liver and red blood cells | Q43603072 | ||
| Urinary sulfur compounds in Down syndrome. | Q43684805 | ||
| Role of cystathionine β-synthase in human breast Cancer | Q43800252 | ||
| The role of hydrogen sulphide in the control of breathing in hypoxic zebrafish (Danio rerio). | Q43803750 | ||
| The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages | Q33875055 | ||
| H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO-TRPA1-CGRP signalling pathway | Q33924111 | ||
| Genetic identification of thiosulfate sulfurtransferase as an adipocyte-expressed antidiabetic target in mice selected for leanness. | Q33924974 | ||
| The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo | Q33942063 | ||
| H2S donor, S-propargyl-cysteine, increases CSE in SGC-7901 and cancer-induced mice: evidence for a novel anti-cancer effect of endogenous H2S? | Q33954567 | ||
| S-diclofenac protects against doxorubicin-induced cardiomyopathy in mice via ameliorating cardiac gap junction remodeling | Q34062431 | ||
| Inhaled hydrogen sulfide induces suspended animation, but does not alter the inflammatory response after blunt chest trauma | Q34076127 | ||
| Brain phenotype of transgenic mice overexpressing cystathionine β-synthase | Q34130338 | ||
| H2S Synthesizing Enzymes: Biochemistry and Molecular Aspects. | Q38545008 | ||
| Hydrogen Sulfide and Urogenital Tract. | Q38545017 | ||
| H2S and Inflammation: An Overview | Q38545022 | ||
| Hydrogen Sulfide and Neuroinflammation | Q38545023 | ||
| H2S and Pain: A Novel Aspect for Processing of Somatic, Visceral and Neuropathic Pain Signals | Q38545028 | ||
| H2S: A New Approach to Lifespan Enhancement and Healthy Ageing? | Q38545032 | ||
| The Pharmacological Effects of S-Propargyl-Cysteine, a Novel Endogenous H2S-Producing Compound | Q38545035 | ||
| Phosphinodithioate and Phosphoramidodithioate Hydrogen Sulfide Donors | Q38545038 | ||
| One- and two-electron oxidation of thiols: mechanisms, kinetics and biological fates | Q38578487 | ||
| A critical review of the literature on hydrogen sulfide toxicity | Q38583535 | ||
| Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Remodeling. | Q38588632 | ||
| Effects of inhibitors of hydrogen sulphide synthesis on rat colonic motility. | Q38649892 | ||
| The Role of Hydrogen Sulfide in Evolution and the Evolution of Hydrogen Sulfide in Metabolism and Signaling | Q38671099 | ||
| The Effects of Oltipraz on Tissue Regeneration in the Process of Wound Healing: A Stereological Study. | Q38679798 | ||
| The role of hydrogen sulfide in burns | Q38704225 | ||
| Hydrogen sulfide in hypertension | Q38710992 | ||
| Discovery of medium ring thiophosphorus based heterocycles as antiproliferative agents | Q38721596 | ||
| Ammonium tetrathiomolybdate as a water-soluble and slow-release hydrogen sulfide donor. | Q38730945 | ||
| Hydrogen Sulfide-Releasing Therapeutics: Translation to the Clinic | Q38733463 | ||
| Synthesis and biological evaluation of novel hydrogen sulfide releasing nicotinic acid derivatives | Q38746792 | ||
| GYY4137 ameliorates intestinal barrier injury in a mouse model of endotoxemia | Q38750577 | ||
| Targeting Cystathionine Beta-Synthase Misfolding in Homocystinuria by Small Ligands: State of the Art and Future Directions | Q38756682 | ||
| Cardioprotection by H2S Donors: Nitric Oxide-Dependent and ‑Independent Mechanisms | Q38762356 | ||
| H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance | Q38775062 | ||
| Diallyl trisulfide protects against ethanol-induced oxidative stress and apoptosis via a hydrogen sulfide-mediated mechanism. | Q38776072 | ||
| Hydrogen sulfide protects H9c2 cardiac cells against doxorubicin-induced cytotoxicity through the PI3K/Akt/FoxO3a pathway | Q38778052 | ||
| The cytotoxicity of garlic-related disulphides and thiosulfonates in WHCO1 oesophageal cancer cells is dependent on S-thiolation and not production of ROS. | Q38779872 | ||
| Synthesis and antitumor activity of ATB-429 derivatives containing a nitric oxide-releasing moiety | Q38784805 | ||
| Synthesis and biological evaluation of novel hydrogen sulfide releasing glycyrrhetic acid derivatives | Q38792152 | ||
| Maternal melatonin or N-acetylcysteine therapy regulates hydrogen sulfide-generating pathway and renal transcriptome to prevent prenatal NG-Nitro-L-arginine-methyl ester (L-NAME)-induced fetal programming of hypertension in adult male offspring. | Q38803978 | ||
| Hydrogen Sulfide Donors Activated by Reactive Oxygen Species | Q38806800 | ||
| A novel slow-releasing hydrogen sulfide donor, FW1256, exerts anti-inflammatory effects in mouse macrophages and in vivo. | Q38809420 | ||
| Macromolecular Hydrogen Sulfide Donors Trigger Spatiotemporally Confined Changes in Cell Signaling. | Q38812934 | ||
| Hydrogen sulfide augments neutrophil migration through enhancement of adhesion molecule expression and prevention of CXCR2 internalization: role of ATP-sensitive potassium channels | Q43909191 | ||
| Management of acute sulfide poisoning. Effects of oxygen, thiosulfate, and nitrite | Q43962352 | ||
| A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia | Q44049327 | ||
| Correction of endothelial dysfunction after selective homocysteine lowering gene therapy reduces arterial thrombogenicity but has no effect on atherogenesis. | Q44088074 | ||
| Polysulfides are possible H2S-derived signaling molecules in rat brain. | Q44122492 | ||
| A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells | Q44131370 | ||
| Hydrogen sulphide triggers VEGF-induced intracellular Ca²⁺ signals in human endothelial cells but not in their immature progenitors. | Q44169318 | ||
| S-propargyl-cysteine (ZYZ-802), a sulphur-containing amino acid, attenuates beta-amyloid-induced cognitive deficits and pro-inflammatory response: involvement of ERK1/2 and NF-κB pathway in rats | Q44301714 | ||
| A novel orally administered trimebutine compound (GIC-1001) is anti-nociceptive and features peripheral opioid agonistic activity and Hydrogen Sulphide-releasing capacity in mice. | Q44333395 | ||
| Hydrogen sulfide prevents ethanol-induced gastric damage in mice: role of ATP-sensitive potassium channels and capsaicin-sensitive primary afferent neurons. | Q44572022 | ||
| Modulation of endogenous production of H2S in rat tissues | Q44653708 | ||
| The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats | Q44691266 | ||
| Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative | Q44706021 | ||
| Hydrogen sulfide induces calcium waves in astrocytes. | Q44735803 | ||
| The interaction of estrogen and CSE/H2S pathway in the development of atherosclerosis | Q44868846 | ||
| Hydrogen sulfide protects neurons from oxidative stress | Q44904699 | ||
| Thiosulfate: a readily accessible source of hydrogen sulfide in oxygen sensing | Q44933023 | ||
| L-Cysteine promotes the proliferation and differentiation of neural stem cells via the CBS/H₂S pathway | Q45005785 | ||
| Peptide-based hydrogen sulphide-releasing gels. | Q45016507 | ||
| Acetylenic enzyme inactivators. Inactivation of gamma-cystathionase, in vitro and in vivo, by propargylglycine | Q45307357 | ||
| Systemic hydrogen sulfide administration partially restores normal alveolarization in an experimental animal model of bronchopulmonary dysplasia | Q45743135 | ||
| Physiological effects of hydrogen sulfide inhalation during exercise in healthy men | Q45782129 | ||
| Cystathionine-beta-synthase gene transfer and 3-deazaadenosine ameliorate inflammatory response in endothelial cells | Q45871031 | ||
| Novel Angiogenic Activity and Molecular Mechanisms of ZYZ-803, a Slow-Releasing Hydrogen Sulfide-Nitric Oxide Hybrid Molecule. | Q45885946 | ||
| Effect of hydrogen sulfide in a porcine model of myocardial ischemia-reperfusion: comparison of different administration regimens and characterization of the cellular mechanisms of protection. | Q45924442 | ||
| S-propargyl-cysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia/hypoxia injury: the contribution of the hydrogen sulfide-mediated pathway. | Q45957950 | ||
| Hydrogen sulfide-releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation. | Q45959353 | ||
| Inhibitory effect of novel diallyldisulfide analogs on HMG-CoA reductase expression in hypercholesterolemic rats: CREB as a potential upstream target. | Q45970576 | ||
| Downregulation of the renal and hepatic hydrogen sulfide (H2S)-producing enzymes and capacity in chronic kidney disease. | Q45986959 | ||
| Role of paraoxonase-1 in the protection of hydrogen sulfide-donating sildenafil (ACS6) against homocysteine-induced neurotoxicity | Q46041979 | ||
| Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats | Q46046531 | ||
| Pancreatic islet overproduction of H2S and suppressed insulin release in Zucker diabetic rats | Q46252508 | ||
| Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice | Q46260974 | ||
| Regulatory effect of hydrogen sulfide on vascular collagen content in spontaneously hypertensive rats | Q46275634 | ||
| Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values | Q46361411 | ||
| Inhibitory effect of copper on cystathionine beta-synthase activity: protective effect of an analog of the human albumin N-terminus | Q46389605 | ||
| Endogenous hydrogen sulfide regulates inflammatory response by activating the ERK pathway in polymicrobial sepsis | Q46392031 | ||
| Structural and Mechanistic Insights into Hemoglobin-catalyzed Hydrogen Sulfide Oxidation and the Fate of Polysulfide Products. | Q46416014 | ||
| Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation | Q46445452 | ||
| Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction | Q46446506 | ||
| Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse | Q46465914 | ||
| Serum free sulfhydryl status is associated with patient and graft survival in renal transplant recipients. | Q46473896 | ||
| The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress | Q46475883 | ||
| Protective effects of diallyl sulfide, a garlic constituent, on the warm hepatic ischemia-reperfusion injury in a rat model. | Q46484123 | ||
| Mitochondria-Targeted Agents: Mitochondriotropics, Mitochondriotoxics, and Mitocans | Q46494088 | ||
| Synthesis of a photocontrollable hydrogen sulfide donor using ketoprofenate photocages | Q46508139 | ||
| Dual role of hydrogen sulfide in mechanical inflammatory hypernociception | Q46514150 | ||
| Hydrogen sulphide is involved in testosterone vascular effect. | Q46568548 | ||
| Hydrogen sulfide regulates lung tissue-oxidized glutathione and total antioxidant capacity in hypoxic pulmonary hypertensive rats | Q46577544 | ||
| Hydrogen sulfide protects rat lung from ischemia-reperfusion injury | Q46593773 | ||
| The possible role of hydrogen sulfide as an endogenous neuromodulator. | Q46606180 | ||
| Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide | Q46621665 | ||
| Changes of the new gaseous transmitter H2S in patients with coronary heart disease | Q46658029 | ||
| Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells | Q46693585 | ||
| High-throughput tandem-microwell assay identifies inhibitors of the hydrogen sulfide signaling pathway | Q46699363 | ||
| Plasma hydrogen sulfide and homocysteine levels in hypertensive patients with different blood pressure levels and complications | Q46701305 | ||
| Hydrogen sulfide accelerates the recovery of kidney tubules after renal ischemia/reperfusion injury | Q46705377 | ||
| Exogenous Hydrogen Sulfide Attenuates Cardiac Fibrosis Through Reactive Oxygen Species Signal Pathways in Experimental Diabetes Mellitus Models | Q46713047 | ||
| Do garlic-derived allyl sulfides scavenge peroxyl radicals? | Q46713306 | ||
| Hemodynamic and metabolic effects of hydrogen sulfide during porcine ischemia/reperfusion injury. | Q46715911 | ||
| Mitochondria-targeted hydrogen sulfide donor AP39 improves neurological outcomes after cardiac arrest in mice. | Q46730611 | ||
| The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. | Q46738154 | ||
| H2S: a universal defense against antibiotics in bacteria | Q46754342 | ||
| Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions | Q46755862 | ||
| Calcium polysulfide overdose: a report of two cases | Q46797896 | ||
| Hydrogen sulphide in the hypothalamus causes an ATP-sensitive K+ channel-dependent decrease in blood pressure in freely moving rats. | Q46803560 | ||
| Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes | Q46833532 | ||
| Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of Brassicaceae? | Q46874690 | ||
| Aspirin augments the concentration of endogenous hydrogen sulfide in mouse brain and liver. | Q46882152 | ||
| Changes in intracellular pH play a secondary role in hydrogen sulfide-induced nasal cytotoxicity | Q46884546 | ||
| Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse | Q46905143 | ||
| Hydrogen sulphide-induced hypothermia attenuates stress-related ulceration in rats | Q46946123 | ||
| Hydrogen sulfide facilitates carotid sinus baroreflex in anesthetized rats | Q46953703 | ||
| Possible role for the novel gasotransmitter hydrogen sulphide in erectile dysfunction--a pilot study | Q46983043 | ||
| Role of KATP channels and TRPV1 receptors in hydrogen sulfide-enhanced gastric emptying of liquid in awake mice | Q47275682 | ||
| Hydrogen Sulfide Protects Renal Grafts Against Prolonged Cold Ischemia-Reperfusion Injury via Specific Mitochondrial Actions | Q47663417 | ||
| All in the timing: a comparison between the cardioprotection induced by H2S preconditioning and post-infarction treatment | Q47690370 | ||
| In situ depot comprising phase-change materials that can sustainably release a gasotransmitter H2S to treat diabetic wounds | Q47751620 | ||
| A timeline of hydrogen sulfide (H2S) research: From environmental toxin to biological mediator | Q47762321 | ||
| Trypsin cleavage of human cystathionine beta-synthase into an evolutionarily conserved active core: structural and functional consequences | Q47800302 | ||
| Inhibition of Mitochondrial Bioenergetics by Esterase-Triggered COS/H2S Donors. | Q47863298 | ||
| A hydrogen sulfide-releasing cyclooxygenase inhibitor markedly accelerates recovery from experimental spinal cord injury | Q47894844 | ||
| Respiratory tract toxicity of inhaled hydrogen sulfide in Fischer-344 rats, Sprague-Dawley rats, and B6C3F1 mice following subchronic (90-day) exposure | Q47966448 | ||
| Neuroprotective effects of lentivirus-mediated cystathionine-beta-synthase overexpression against 6-OHDA-induced parkinson's disease rats | Q48003246 | ||
| Hydrogen sulfide induces heme oxygenase-1 in human kidney cells. | Q48009046 | ||
| Nucleoside monophosphorothioates as the new hydrogen sulfide precursors with unique properties. | Q48022089 | ||
| AP39, a mitochondria-targeting hydrogen sulfide (H2 S) donor, protects against myocardial reperfusion injury independently of salvage kinase signalling | Q48024405 | ||
| Biogenesis of Hydrogen Sulfide and Thioethers by Cystathionine Beta-Synthase | Q48032377 | ||
| Pharmacological characterization of the vascular effects of aryl isothiocyanates: is hydrogen sulfide the real player? | Q48034814 | ||
| Hydrogen sulfide intoxication | Q48070542 | ||
| Hydrogen Sulfide Inhalation Improves Neurological Outcome via NF-κB-Mediated Inflammatory Pathway in a Rat Model of Cardiac Arrest and Resuscitation | Q48087988 | ||
| Experimental beta-alaninuria induced by (aminooxy)acetate | Q48252645 | ||
| Cystathionine-β-Synthase Gene Transfer Into Rostral Ventrolateral Medulla Exacerbates Hypertension via Nitric Oxide in Spontaneously Hypertensive Rats | Q48356680 | ||
| Bio-orthogonal "click-and-release" donation of caged carbonyl sulfide (COS) and hydrogen sulfide (H2S). | Q48364614 | ||
| N-Acetylcysteine ethyl ester (NACET): a novel lipophilic cell-permeable cysteine derivative with an unusual pharmacokinetic feature and remarkable antioxidant potential. | Q48366429 | ||
| Expression of 3-Mercaptopyruvate Sulfurtransferase in the Mouse. | Q48395944 | ||
| Is development of high-grade gliomas sulfur-dependent? | Q48403130 | ||
| A functional transsulfuration pathway in the brain links to glutathione homeostasis | Q48411596 | ||
| Cystathionase activity in rat tissues during development | Q48508782 | ||
| Effects of hydrogen sulfide on a rat model of sepsis-associated encephalopathy | Q48805640 | ||
| Hydrogen Sulfide Regulates the [Ca2+]i Level in the Primary Medullary Neurons | Q37389882 | ||
| Gp130-mediated STAT3 activation by S-propargyl-cysteine, an endogenous hydrogen sulfide initiator, prevents doxorubicin-induced cardiotoxicity. | Q37412473 | ||
| The novel mitochondria-targeted hydrogen sulfide (H2S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro | Q37420836 | ||
| Effect of endotoxemia in mice genetically deficient in cystathionine-γ-lyase, cystathionine-β-synthase or 3-mercaptopyruvate sulfurtransferase. | Q37426673 | ||
| Potential applications of hydrogen sulfide-induced suspended animation | Q37438086 | ||
| Is hydrogen sulfide a circulating "gasotransmitter" in vertebrate blood? | Q37441330 | ||
| Inhibition of cystathionine β-synthetase suppresses sodium channel activities of dorsal root ganglion neurons of rats with lumbar disc herniation | Q37459943 | ||
| Cystathionine γ-lyase deficiency protects mice from galactosamine/lipopolysaccharide-induced acute liver failure | Q37460255 | ||
| Beneficial effect of a hydrogen sulphide donor (sodium sulphide) in an ovine model of burn- and smoke-induced acute lung injury | Q37481192 | ||
| Bench-to-bedside review: Hydrogen sulfide--the third gaseous transmitter: applications for critical care | Q37516593 | ||
| Keap1 cysteine 288 as a potential target for diallyl trisulfide-induced Nrf2 activation | Q37525077 | ||
| The Effects of Different Garlic-Derived Allyl Sulfides on Anaerobic Sulfur Metabolism in the Mouse Kidney | Q37533626 | ||
| Enzymology of H2S biogenesis, decay and signaling | Q37543232 | ||
| Production and physiological effects of hydrogen sulfide. | Q37544124 | ||
| Coenzyme Q deficiency causes impairment of the sulfide oxidation pathway. | Q37555498 | ||
| CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome. | Q37555654 | ||
| Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth | Q37568665 | ||
| YAP and 14-3-3γ are involved in HS-OA-induced growth inhibition of hepatocellular carcinoma cells: A novel mechanism for hydrogen sulfide releasing oleanolic acid | Q37588424 | ||
| The New Synthetic H2S-Releasing SDSS Protects MC3T3-E1 Osteoblasts against H2O2-Induced Apoptosis by Suppressing Oxidative Stress, Inhibiting MAPKs, and Activating the PI3K/Akt Pathway | Q37595201 | ||
| Making and working with hydrogen sulfide: The chemistry and generation of hydrogen sulfide in vitro and its measurement in vivo: a review | Q37601063 | ||
| Hydrogen sulfide's involvement in modulating nociception. | Q37604899 | ||
| Provisional Advisory Levels (PALs) for hydrogen sulfide (H2S). | Q37614541 | ||
| Correction of cystathionine β-synthase deficiency in mice by treatment with proteasome inhibitors | Q37615678 | ||
| S-sulfhydration as a cellular redox regulation | Q37626815 | ||
| Gases in the mitochondria | Q37652506 | ||
| Gasotransmitters in cancer: from pathophysiology to experimental therapy | Q37656625 | ||
| Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin | Q37686235 | ||
| Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms | Q37686284 | ||
| Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects | Q37686288 | ||
| Mechanisms of angiogenesis: role of hydrogen sulphide | Q37690808 | ||
| Catalase as a sulfide-sulfur oxido-reductase: An ancient (and modern?) regulator of reactive sulfur species (RSS). | Q37700190 | ||
| H2S biosynthesis and catabolism: new insights from molecular studies | Q37709987 | ||
| Cardiovascular disease and resuscitated septic shock lead to the downregulation of the H2S-producing enzyme cystathionine-γ-lyase in the porcine coronary artery | Q37712551 | ||
| L-methionine-dl-sulfoxide metabolism and toxicity in freshly isolated mouse hepatocytes: gender differences and inhibition with aminooxyacetic acid | Q36952093 | ||
| S-Propargyl-cysteine Exerts a Novel Protective Effect on Methionine and Choline Deficient Diet-Induced Fatty Liver via Akt/Nrf2/HO-1 Pathway | Q36969802 | ||
| Hydrogen sulphide and its therapeutic potential | Q36975742 | ||
| Biosynthesis of H2S is impaired in non-obese diabetic (NOD) mice. | Q36977469 | ||
| Role of garlic in the prevention of ischemia-reperfusion injury. | Q36983870 | ||
| Hydrogen Sulfide Contributes to Retinal Neovascularization in Ischemia-Induced Retinopathy | Q36997322 | ||
| A H 2 S Donor GYY4137 Exacerbates Cisplatin-Induced Nephrotoxicity in Mice. | Q37000218 | ||
| H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G | Q37002373 | ||
| Production of hydrogen sulfide from d-cysteine and its therapeutic potential. | Q37016283 | ||
| Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer | Q37049363 | ||
| Primary hepatocytes from mice lacking cysteine dioxygenase show increased cysteine concentrations and higher rates of metabolism of cysteine to hydrogen sulfide and thiosulfate | Q37059694 | ||
| Prodrugs: design and clinical applications. | Q37064858 | ||
| Oxygen-sensitive mitochondrial accumulation of cystathionine β-synthase mediated by Lon protease | Q37068583 | ||
| Garlic oil polysulfides: H2S- and O2-independent prooxidants in buffer and antioxidants in cells | Q37071845 | ||
| Controllable hydrogen sulfide donors and their activity against myocardial ischemia-reperfusion injury | Q37097747 | ||
| The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice | Q37122696 | ||
| Effect of Hydrogen Sulfide Donors on Intraocular Pressure in Rabbits | Q37125134 | ||
| Hydrogen sulfide triggers late-phase preconditioning in postischemic small intestine by an NO- and p38 MAPK-dependent mechanism | Q37138975 | ||
| Inhibition of cystine uptake disrupts the growth of primary brain tumors | Q37189377 | ||
| Synthesis and evaluation of phosphorodithioate-based hydrogen sulfide donors. | Q37213154 | ||
| The cysteine dioxgenase knockout mouse: altered cysteine metabolism in nonhepatic tissues leads to excess H2S/HS(-) production and evidence of pancreatic and lung toxicity | Q37216462 | ||
| Zofenopril Protects Against Myocardial Ischemia-Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability | Q37240724 | ||
| A novel hydrogen sulfide prodrug, SG1002, promotes hydrogen sulfide and nitric oxide bioavailability in heart failure patients | Q37279303 | ||
| Pro-inflammatory effects of hydrogen sulphide on substance P in caerulein-induced acute pancreatitis | Q37293868 | ||
| Inducible hydrogen sulfide synthesis in chondrocytes and mesenchymal progenitor cells: is H2S a novel cytoprotective mediator in the inflamed joint? | Q37294661 | ||
| The complex effects of the slow-releasing hydrogen sulfide donor GYY4137 in a model of acute joint inflammation and in human cartilage cells. | Q37295023 | ||
| Hydrogen sulfide mediates cardioprotection through Nrf2 signaling | Q37328256 | ||
| Polysulfides link H2S to protein thiol oxidation. | Q37334548 | ||
| S-propargyl-cysteine attenuates inflammatory response in rheumatoid arthritis by modulating the Nrf2-ARE signaling pathway | Q37343152 | ||
| Cystathionine-beta-synthase inhibition for colon cancer: Enhancement of the efficacy of aminooxyacetic acid via the prodrug approach. | Q37353949 | ||
| Hydrogen Sulfide Regulates Krüppel-Like Factor 5 Transcription Activity via Specificity Protein 1 S-Sulfhydration at Cys664 to Prevent Myocardial Hypertrophy. | Q37364524 | ||
| The hydrogen sulfide donor, Lawesson's reagent, prevents alendronate-induced gastric damage in rats. | Q37371504 | ||
| Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells. | Q37371516 | ||
| Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury. | Q37379431 | ||
| Exogenous and Endogenous Hydrogen Sulfide Protects Gastric Mucosa against the Formation and Time-Dependent Development of Ischemia/Reperfusion-Induced Acute Lesions Progressing into Deeper Ulcerations. | Q50185789 | ||
| Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke | Q50203349 | ||
| Development of photo-controllable hydrogen sulfide donor applicable in live cells | Q50219423 | ||
| Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia | Q50224206 | ||
| Potential role of the gaseous mediator hydrogen sulphide (H2S) in inhibition of human colonic contractility | Q50452581 | ||
| The hydrogen sulfide releasing compounds ATB-346 and diallyl trisulfide attenuate streptozotocin-induced cognitive impairment, neuroinflammation, and oxidative stress in rats: involvement of asymmetric dimethylarginine. | Q50519678 | ||
| Sulfhemoglobinemia after dermal application of DMSO. | Q50524694 | ||
| Effects of acetylsalicylic acid on the levels of sulfane sulfur and non-protein sulfhydryl groups in mouse tissues. | Q50749737 | ||
| Lipoic Acid as a Possible Pharmacological Source of Hydrogen Sulfide/Sulfane Sulfur. | Q50863448 | ||
| Colorimetric detection of endogenous hydrogen sulfide production in living cells. | Q50924344 | ||
| Delayed sulfhemoglobinemia after acute dapsone intoxication. | Q50934967 | ||
| Exercise Increases Cystathionine-γ-lyase Expression and Decreases the Status of Oxidative Stress in Myocardium of Ovariectomized Rats. | Q50950978 | ||
| Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia. | Q50963577 | ||
| Effects of 10-ppm hydrogen sulfide inhalation in exercising men and women. Cardiovascular, metabolic, and biochemical responses. | Q50971574 | ||
| Effects of 5 ppm hydrogen sulfide inhalation on biochemical properties of skeletal muscle in exercising men and women. | Q51032144 | ||
| Correlation between levels of exhaled hydrogen sulfide and airway inflammatory phenotype in patients with chronic persistent asthma. | Q51047167 | ||
| Effect of the hydrogen sulfide donor GYY4137 on platelet activation and microvascular thrombus formation in mice. | Q51068380 | ||
| Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases. | Q51116354 | ||
| Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats. | Q51119493 | ||
| Novel H2S Releasing Nano-fibrous Coating for In Vivo Dermal Wound Regeneration. | Q51209959 | ||
| Lung inflation with hydrogen sulfide during the warm ischemia phase ameliorates injury in rat donor lungs via metabolic inhibition after cardiac death. | Q51252388 | ||
| Relevant variations and neuroprotecive effect of hydrogen sulfide in a rat glaucoma model. | Q51301277 | ||
| Protective effects of exogenous and endogenous hydrogen sulfide in mast cell-mediated pruritus and cutaneous acute inflammation in mice. | Q51329487 | ||
| ATB-346, a novel hydrogen sulfide-releasing anti-inflammatory drug, induces apoptosis of human melanoma cells and inhibits melanoma development in vivo. | Q51365513 | ||
| Both the H2S biosynthesis inhibitor aminooxyacetic acid and the mitochondrially targeted H2S donor AP39 exert protective effects in a mouse model of burn injury. | Q51495600 | ||
| Whatever happened to …. | Q51500537 | ||
| S-allyl-L-cysteine and isoliquiritigenin improve mitochondrial function in cellular models of oxidative and nitrosative stress. | Q51583169 | ||
| Sodium thiosulfate protects brain in rat model of adenine induced vascular calcification. | Q51595850 | ||
| Potentiation of Hypoxic Pulmonary Vasoconstriction by Hydrogen Sulfide Precursors 3-Mercaptopyruvate and D-Cysteine Is Blocked by the Cystathionine γ Lyase Inhibitor Propargylglycine. | Q51601346 | ||
| Homocystinuria--the effects of betaine in the treatment of patients not responsive to pyridoxine. | Q51646110 | ||
| Hydrogen Sulfide Induces Keap1 S-sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis via Nrf2 Activation. | Q51687105 | ||
| Exhaled Hydrogen Sulfide Predicts Airway Inflammation Phenotype in COPD. | Q51689166 | ||
| Neuroprotective effect of S-allyl-l-cysteine derivatives against endoplasmic reticulum stress-induced cytotoxicity is independent of calpain inhibition. | Q52142904 | ||
| Diallyl Trisulfide Is a Fast H2S Donor, but Diallyl Disulfide Is a Slow One: The Reaction Pathways and Intermediates of Glutathione with Polysulfides. | Q52815584 | ||
| [Regulation of hydrogen sulfide on transporter protein Bsep and Mdr2 in acute liver failure]. | Q52887221 | ||
| The effects of hydrogen sulfide on platelet-leukocyte aggregation and microvascular thrombolysis. | Q52968284 | ||
| Hydrogen sulfide improves colonic barrier integrity in DSS-induced inflammation in Caco-2 cells and mice. | Q53059481 | ||
| Novel hydrogen sulfide-releasing compound, S-propargyl-cysteine, prevents STZ-induced diabetic nephropathy. | Q53127535 | ||
| Hydrogen sulfide producing enzymes in pregnancy and preeclampsia. | Q53181366 | ||
| Organosulfide profile and hydrogen sulfide-releasing capacity of stinky bean (Parkia speciosa) oil: Effects of pH and extraction methods. | Q53204969 | ||
| Hydrogen sulfide ameliorates acute lung injury induced by infrarenal aortic cross-clamping by inhibiting inflammation and angiopoietin 2 release. | Q53205137 | ||
| Myocardial and lung injuries induced by hydrogen sulfide and the effectiveness of oxygen therapy in rats. | Q53253915 | ||
| Applications of Synthetic Organic Tetrasulfides as H2S Donors. | Q53335172 | ||
| Reversal of endothelial dysfunction in aorta of streptozotocin-nicotinamide-induced type-2 diabetic rats by S-Allylcysteine. | Q53465500 | ||
| Hydrogen sulfide releasing naproxen offers better anti-inflammatory and chondroprotective effect relative to naproxen in a rat model of zymosan induced arthritis. | Q53508791 | ||
| Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative, on carrageenan-induced hindpaw oedema formation in the rat. | Q53548199 | ||
| Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension: Randomized, Double-Blind, Placebo-Controlled Study. | Q53640921 | ||
| Effects of AP39, a novel triphenylphosphonium derivatised anethole dithiolethione hydrogen sulfide donor, on rat haemodynamic parameters and chloride and calcium Cav3 and RyR2 channels. | Q53647294 | ||
| Sodium thiosulfate attenuates angiotensin II-induced hypertension, proteinuria and renal damage. | Q54182308 | ||
| Synthesis and Pharmacological Evaluation of Novel Adenine-Hydrogen Sulfide Slow Release Hybrids Designed as Multitarget Cardioprotective Agents. | Q54186047 | ||
| Protein kinase G Iα oxidation paradoxically underlies blood pressure lowering by the reductant hydrogen sulfide. | Q54318607 | ||
| Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 [corrected](NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice. | Q54397165 | ||
| New biologically active hydrogen sulfide donors. | Q54782602 | ||
| Insights into the mechanism of the reaction between hydrogen sulfide and peroxynitrite | Q56971548 | ||
| Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID | Q57144376 | ||
| Hydrogen sulfide compensates nitric oxide deficiency in murine corpus cavernosum | Q57718561 | ||
| Hydrogen sulfide is involved in dexamethasone-induced hypertension in rat | Q57718569 | ||
| Maternal N-acetylcysteine therapy regulates hydrogen sulfide-generating pathway and prevents programmed hypertension in male offspring exposed to prenatal dexamethasone and postnatal high-fat diet | Q57845133 | ||
| Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide | Q57931896 | ||
| Why Can Hydrogen Sulfide Permeate Cell Membranes? | Q58987030 | ||
| Thioglycine and l-thiovaline: Biologically active H2S-donors | Q60695399 | ||
| Gastrointestinal Safety and Anti-Inflammatory Effects of a Hydrogen Sulfide–Releasing Diclofenac Derivative in the Rat | Q60695408 | ||
| 5-Amino-2-hydroxybenzoic Acid 4-(5-Thioxo-5H-[1,2]dithiol-3yl)-phenyl Ester (ATB-429), a Hydrogen Sulfide-Releasing Derivative of Mesalamine, Exerts Antinociceptive Effects in a Model of Postinflammatory Hypersensitivity | Q60695409 | ||
| Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of | Q63965443 | ||
| Pharmacological activation and genetic manipulation of cystathionine beta-synthase alter circulating levels of homocysteine and hydrogen sulfide in mice | Q64374785 | ||
| Modifiers of mercaptopyruvate sulfurtransferase catalyzed conversion of cyanide to thiocyanate in vitro | Q67559562 | ||
| Effects of hydrogen sulfide exposure on lung mitochondrial respiratory chain enzymes in rats | Q68459824 | ||
| The treatment of hydrogen sulfide intoxication: oxygen versus nitrites | Q70258969 | ||
| The effect of three alpha-keto acids on 3-mercaptopyruvate sulfurtransferase activity | Q71528980 | ||
| Effects of 10-ppm hydrogen sulfide inhalation on pulmonary function in healthy men and women | Q71741533 | ||
| Specificity studies of 3-Mercaptopyruvate sulfurtransferase | Q71814547 | ||
| Early diagnosis and treatment of homocystinuria | Q72875786 | ||
| Sulphide as an inhibitor and electron donor for the cytochrome c oxidase system | Q72949661 | ||
| An adolescent case of sulfhemoglobinemia associated with high-dose metoclopramide and N-acetylcysteine | Q73026111 | ||
| Domain architecture of the heme-independent yeast cystathionine beta-synthase provides insights into mechanisms of catalysis and regulation | Q74217092 | ||
| Effects of aminooxyacetate on glutamate compartmentation and TCA cycle kinetics in rat hearts | Q74255333 | ||
| The activity of 3-mercaptopyruvate sulfurtransferase in erythrocytes from patients with polycythemia vera | Q74538449 | ||
| The glutathione dependence of inorganic sulfate formation from L- or D-cysteine in isolated rat hepatocytes | Q74605312 | ||
| A crystalline enzyme that cleaves homoserine and cystathionine. II. Prosthetic group | Q77071638 | ||
| Evidence for heme-mediated redox regulation of human cystathionine beta-synthase activity | Q77300083 | ||
| Anethole dithiolethione, a putative neuroprotectant, increases intracellular and extracellular glutathione levels during starvation of cultured astroglial cells | Q77763649 | ||
| Endogenous hydrogen sulfide overproduction in Down syndrome | Q78720991 | ||
| Hydrogen sulfide acts as an inflammatory mediator in cecal ligation and puncture-induced sepsis in mice by upregulating the production of cytokines and chemokines via NF-kappaB | Q79512390 | ||
| [Plasma level of endogenous hydrogen sulfide in patients with acute asthma] | Q79642051 | ||
| The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat | Q80027203 | ||
| Suspended animation-like state protects mice from lethal hypoxia | Q80111384 | ||
| Hydrogen sulphide regulates intracellular pH in vascular smooth muscle cells | Q80389174 | ||
| Endogenous hydrogen sulfide regulates leukocyte trafficking in cecal ligation and puncture-induced sepsis | Q80545026 | ||
| Treatment with H2S-releasing diclofenac protects mice against acute pancreatitis-associated lung injury | Q80590460 | ||
| The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation | Q80613445 | ||
| Hydrogen sulfide enhances ulcer healing in rats | Q80624339 | ||
| Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways | Q80732265 | ||
| Protective effect of hydrogen sulfide in a murine model of acute lung injury induced by combined burn and smoke inhalation | Q80809383 | ||
| A point mutation in a silencer module reduces the promoter activity for the human mercaptopyruvate sulfurtransferase | Q80912932 | ||
| S-allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway | Q80980892 | ||
| Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling | Q81098816 | ||
| Use of Lawesson's reagent in organic syntheses | Q81293632 | ||
| Medicine. Nothing rotten about hydrogen sulfide's medical promise | Q81358069 | ||
| Regulatory effects of hydrogen sulfide on IL-6, IL-8 and IL-10 levels in the plasma and pulmonary tissue of rats with acute lung injury | Q81411464 | ||
| Prevention of hydrogen sulfide (H2S)-induced mouse lethality and cytotoxicity by hydroxocobalamin (vitamin B(12a)) | Q81538824 | ||
| Polarographic measurement of hydrogen sulfide production and consumption by mammalian tissues | Q81706798 | ||
| Passive loss of hydrogen sulfide in biological experiments | Q82362478 | ||
| The effects of garlic-derived sulfur compounds on cell proliferation, caspase 3 activity, thiol levels and anaerobic sulfur metabolism in human hepatoblastoma HepG2 cells | Q82563538 | ||
| Determination of S-propargyl-cysteine in rat plasma by mixed-mode reversed-phase and cation-exchange HPLC-MS/MS method and its application to pharmacokinetic studies | Q82878851 | ||
| S-propargyl-cysteine, a novel hydrogen sulfide-modulated agent, attenuated tumor necrosis factor-α-induced inflammatory signaling and dysfunction in endothelial cells | Q83222411 | ||
| ACS84, a novel hydrogen sulfide-releasing compound, protects against amyloid β-induced cell cytotoxicity | Q83385623 | ||
| Calcium sulfide (CaS), a donor of hydrogen sulfide (H(2)S): a new antihypertensive drug? | Q83746870 | ||
| Inhaled hydrogen sulfide protects against ventilator-induced lung injury | Q84468122 | ||
| Effects of intravenous sulfide during porcine aortic occlusion-induced kidney ischemia/reperfusion injury | Q84596416 | ||
| Synthesis of a Fe(II)SH complex stabilized by an intramolecular N-H···S hydrogen bond, which acts as a H2S donor | Q84945958 | ||
| Hydrogen sulfide contributes to hypoxia-induced radioresistance on hepatoma cells | Q84999681 | ||
| Effects of conventional and hydrogen sulfide-releasing non-steroidal anti-inflammatory drugs in rats with stress-induced and epinephrine-induced gastric damage | Q85341704 | ||
| The effect of CSE gene deletion in caerulein-induced acute pancreatitis in the mouse | Q85641160 | ||
| Hydrogen sulfide is produced by cystathionine γ-lyase at the steady-state low intracellular Ca(2+) concentrations | Q85892282 | ||
| Physicochemical characteristics and gastrointestinal absorption behaviors of S-propargyl-cysteine, a potential new drug candidate for cardiovascular protection and antitumor treatment | Q85914710 | ||
| Potential role of hydrogen sulfide in the pathogenesis of vascular dysfunction in septic shock | Q86420474 | ||
| Identification of cystathionine β-synthase inhibitors using a hydrogen sulfide selective probe | Q86434332 | ||
| Estrogens increase cystathionine-γ-lyase expression and decrease inflammation and oxidative stress in the myocardium of ovariectomized rats | Q86567066 | ||
| Anti-inflammatory and cytoprotective properties of hydrogen sulfide | Q86881583 | ||
| S-aroylthiooximes: a facile route to hydrogen sulfide releasing compounds with structure-dependent release kinetics | Q87370467 | ||
| Hydrogen sulfide-releasing aspirin derivative ACS14 exerts strong antithrombotic effects in vitro and in vivo | Q87397480 | ||
| Hydrogen sulfide inhibits human platelet aggregation in vitro in part by interfering gap junction channels: effects of ACS14, a hydrogen sulfide-releasing aspirin | Q87421006 | ||
| Outcome after hydrogen sulphide intoxication | Q87502766 | ||
| Cystathionine-gamma-lyase deficient mice are protected against the development of multiorgan failure and exhibit reduced inflammatory response during burn | Q87610780 | ||
| The cystathionine γ-lyase/hydrogen sulfide system maintains cellular glutathione status | Q87627634 | ||
| Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer | Q87713329 | ||
| Effect of processing conditions on the organosulfides of shallot (Allium cepa L. Aggregatum group) | Q87905365 | ||
| Design and synthesis of polymeric hydrogen sulfide donors | Q88106978 | ||
| Design, synthesis and biological evaluation of hydrogen sulfide releasing derivatives of 3-n-butylphthalide as potential antiplatelet and antithrombotic agents | Q88204611 | ||
| Garlic-inspired trisulfide linkers for thiol-stimulated H2S release | Q88436528 | ||
| Esterase Activated Carbonyl Sulfide/Hydrogen Sulfide (H2S) Donors | Q89022568 | ||
| Discovery of a ring-opened derivative of 3-n-butylphthalide bearing NO/H2S-donating moieties as a potential anti-ischemic stroke agent | Q89092897 | ||
| Hydrogen sulfide modulates sub-cellular susceptibility to oxidative stress induced by myocardial ischemic reperfusion injury | Q89112299 | ||
| Synthesis and biological evaluation of nitric oxide (NO)-hydrogen sulfide (H2S) releasing derivatives of (S)-3-n-butylphthalide as potential antiplatelet agents | Q89415079 | ||
| pH-Controlled Hydrogen Sulfide Release for Myocardial Ischemia-Reperfusion Injury | Q89422157 | ||
| Discovery of selective cystathionine β-synthase inhibitors by high-throughput screening with a fluorescent thiol probe | Q90949122 | ||
| P433 | issue | 4 | |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 497-564 | |
| P577 | publication date | 2017-10-01 | |
| P1433 | published in | Pharmacological Reviews | Q2085079 |
| P1476 | title | International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors | |
| P478 | volume | 69 |
| Q47762321 | A timeline of hydrogen sulfide (H2S) research: From environmental toxin to biological mediator |
| Q61456104 | AP39, a Modulator of Mitochondrial Bioenergetics, Reduces Antiangiogenic Response and Oxidative Stress in Hypoxia-Exposed Trophoblasts |
| Q57477623 | AP39, a modulator of mitochondrial bioenergetics, reduces anti-angiogenic response and oxidative stress in hypoxia-exposed trophoblasts: relevance for preeclampsia pathogenesis |
| Q90285254 | Activatable Small-Molecule Hydrogen Sulfide Donors |
| Q90481348 | Aminooxyacetic acid (AOAA) sensitizes colon cancer cells to oxaliplatin via exaggerating apoptosis induced by ROS |
| Q89575848 | Cardiovascular phenotype of mice lacking 3-mercaptopyruvate sulfurtransferase |
| Q59128961 | Clopidogrel as a donor probe and thioenol derivatives as flexible promoieties for enabling HS biomedicine |
| Q92486507 | Crystal structure of 7,8,15,16,17-penta-thiadi-spiro-[5.2.59.36]hepta-deca-ne |
| Q88491124 | Cysteine-activated hydrogen sulfide (H2S) delivery through caged carbonyl sulfide (COS) donor motifs |
| Q92180942 | Dithioesters: simple, tunable, cysteine-selective H2S donors |
| Q90719796 | Effects of sulfane sulfur content in benzyl polysulfides on thiol-triggered H2S release and cell proliferation |
| Q89477002 | Emerging pharmacological tools to control hydrogen sulfide signaling in critical illness |
| Q89740239 | Enhanced Analgesic Effects and Gastrointestinal Safety of a Novel, Hydrogen Sulfide-Releasing Anti-Inflammatory Drug (ATB-352): A Role for Endogenous Cannabinoids |
| Q64992903 | Fluorogenic hydrogen sulfide (H2S) donors based on sulfenyl thiocarbonates enable H2S tracking and quantification. |
| Q58728320 | GYY4137 Promotes Mice Feeding Behavior via Arcuate Nucleus Sulfur-Sulfhydrylation and AMPK Activation |
| Q89805532 | Generation and Characterization of a CRISPR/Cas9 -Induced 3-mst Deficient Zebrafish |
| Q57193344 | Generation of controllable gaseous HS concentrations using microfluidics |
| Q64255204 | HS suppresses indoleamine 2, 3-dioxygenase 1 and exhibits immunotherapeutic efficacy in murine hepatocellular carcinoma |
| Q57463007 | HS: a Bacterial Defense Mechanism Against the Host Immune Response |
| Q92591238 | Hydrogen Sulfide Plays an Important Protective Role through Influencing Endoplasmic Reticulum Stress in Diseases |
| Q58788258 | Hydrogen Sulfide-Releasing Fibrous Membranes: Potential Patches for Stimulating Human Stem Cells Proliferation and Viability under Oxidative Stress |
| Q48051045 | Kinetic Insights into Hydrogen Sulfide Delivery from Caged-Carbonyl Sulfide Isomeric Donor Platforms. |
| Q92011868 | Manganese Porphyrin-Based SOD Mimetics Produce Polysulfides from Hydrogen Sulfide |
| Q91797316 | Neuroprotective effects of ammonium tetrathiomolybdate, a slow-release sulfide donor, in a rodent model of regional stroke |
| Q55039774 | New aspects of antiproliferative activity of 4-hydroxybenzyl isothiocyanate, a natural H2S-donor. |
| Q93086364 | Overproduction of H2S, generated by CBS, inhibits mitochondrial Complex IV and suppresses oxidative phosphorylation in Down syndrome |
| Q92309834 | Products of Sulfide/Selenite Interaction Possess Antioxidant Properties, Scavenge Superoxide-Derived Radicals, React with DNA, and Modulate Blood Pressure and Tension of Isolated Thoracic Aorta |
| Q91709627 | Reactive oxygen species-triggered off-on fluorescence donor for imaging hydrogen sulfide delivery in living cells |
| Q90397862 | Role of 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation, Migration, and Bioenergetics in Murine Colon Cancer Cells |
| Q64967388 | Sodium sulfide selectively induces oxidative stress, DNA damage, and mitochondrial dysfunction and radiosensitizes glioblastoma (GBM) cells. |
| Q64063015 | Sulfide (Na₂S) and Polysulfide (Na₂S₂) Interacting with Doxycycline Produce/Scavenge Superoxide and Hydroxyl Radicals and Induce/Inhibit DNA Cleavage |
| Q92442181 | The Inhibitory Effects of Slow-Releasing Hydrogen Sulfide Donors in the Mechanical Allodynia, Grip Strength Deficits, and Depressive-Like Behaviors Associated with Chronic Osteoarthritis Pain |
| Q57037503 | Thionoesters: A Native Chemical Ligation-Inspired Approach to Cysteine-Triggered HS Donors |
Search more.